BPC-157 Evidence Guide: Research Models and Evidence Limits

Important boundary: This article reviews published evidence. BioPep USA products are for lawful research use only and are not for human or animal consumption, injection, diagnosis, treatment, or disease prevention.

Published BPC-157 material includes preclinical experiments and recent reviews. Those sources must be separated by study type. The FDA has not approved BPC-157 for human use.

What the selected evidence includes

A 2015 paper reported wound-model observations in animals and cell experiments. Two later reviews examine the broader BPC-157 literature, including the limits of the available evidence. A review summarizes prior work; it is not a new controlled trial.

What the evidence does not establish

  • It does not make a research-use product an approved medication.
  • Animal and cell findings cannot be presented as proven human outcomes.
  • The cited papers do not provide BioPep USA product-use instructions.

BioPep USA records

Regulatory reference

The FDA review of BPC-157-related bulk drug substances discusses regulatory status and limitations of the available evidence. Research findings do not authorize use of BioPep USA products in people or animals.

Selected PubMed sources

  1. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.. Drug Des Devel Ther. 2015. PMID: 25995620.
  2. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.. Pharmaceuticals (Basel). 2025 Jan 30. PMID: 40005999.
  3. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.. HSS J. 2025 Jul 31. PMID: 40756949.

Last reviewed: September 15, 2026.